This update includes: A Sign-On Letter Urging Senate Action on Telehealth Legislation This Fall Alliance comment letter on Medicare Advantage Joint study by CMS, CDC, and NIH on Telehealth for Opioid Use Disorder Services During COVID-19 Pandemic and notable research and news developments
Mayo Clinic Proceedings: Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality The Mayo Clinic conducted a retrospective analysis that included patients diagnosed with COVID-19 at risk for severe disease who enrolled in the health system’s remote patient monitoring (RPM) program between March 2020 - October 2021. [...]
JAMA Network Open: Assessment of Clinician Diagnostic Concordance with Video Telemedicine in the Integrated Multispecialty Practice at Mayo Clinic During the Beginning of COVID-19 Pandemic From March to June 2020 Researchers from Mayo Clinic conducted a study examining how concordant to an in-person diagnosis provisional diagnoses established at a video telemedicine visit are [...]
J Endocrinol Invest: A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial Purpose: To evaluate if a web-based telemedicine system (the Glucoonline® system) is effective to improve glucose control in insulin-treated patients with type 1 and type 2 diabetes, as compared to standard of care. [...]